Compounds > n-(2-hydroxypropyl)methacrylamide
Page last updated: 2024-08-23

n-(2-hydroxypropyl)methacrylamide and Experimental Mammary Neoplasms

n-(2-hydroxypropyl)methacrylamide has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, H; Chen, K; Chen, W; Gong, Q; Luo, K; Ou, Y; Wang, J; Zhang, H1

Other Studies

1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Experimental Mammary Neoplasms

ArticleYear
Enzyme/pH-sensitive polyHPMA-DOX conjugate as a biocompatible and efficient anticancer agent.
    Biomaterials science, 2018, May-01, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Doxorubicin; Drug Liberation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoconjugates; Polymethacrylic Acids

2018